by CN Bio. | Sep 8, 2020 | Uncategorised
CN Bio and Imperial College London collaborate to identify novel treatments for alcoholic hepatitis. CN Bio’s Liver-on-Chip technology to define underlying disease mechanisms and screen therapeutic targets. CN Bio, a leading cell culture company, that has developed...
by CN Bio. | Jun 9, 2020 | Uncategorised
Paper published in Nature Metabolism demonstrates novel pathway regulating the underlying mechanism of liver fibrosis Research harnesses CN Bio’s liver-on-chip NASH disease model, to advance development of potential new medicines for liver fibrosis CN Bio, a...
